HEPA Hepion Pharmaceuticals Inc

EquitiesIQ announced today that Robert Foster, B.Sc. (Pharm), Pharm.D., Ph.D., Chief Executive Officer of Hepion Pharmaceuticals (NASDAQ: HEPA), will present at the EquitiesIQ Q4 2021 Investor Forum, a virtual investor event series. Dr. Foster’s presentation will be made available for on-demand viewing at 8 AM ET on November 4, 2021.

In advance of the presentation, Dr. Foster participated in a short interview to discuss recent milestones and upcoming catalysts at Hepion Pharmaceuticals. To watch the interview, visit: https://www.equitiesiq.com/hepa/.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

Presentation Details

• Event Series: EquitiesIQ Q4 2021 Investor Forum
• Presenter: Robert Foster, B.Sc. (Pharm), Pharm.D., Ph.D.
• Date: November 4, 2021 at 8 AM ET
• Webcast: https://www.equitiesiq.com/hepa/

About EquitiesIQThe EquitiesIQ Investor Forum is a global investor event series featuring presentations from top executives at established and emerging public companies. EquitiesIQ works with companies to remotely capture high-quality video of their presentation, as well as a short interview with the presenter, which are then edited for maximum impact and made available to watch on-demand. EquitiesIQ is proud to empower innovative companies to reach new investors and partners across multiple verticals. For more information, visit: https://www.equitiesiq.com/.

Important DisclaimersPresentations and interviews may contain forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected and may vary from company to company. Presenter’s opinions are their own and do not necessarily reflect the views of EquitiesIQ. Presentations are pre-recorded and reflect information as of the publication date.

EquitiesIQ Contactinfo@equitiesiq.com